Medifast Non-GAAP EPS of $3.32, revenue of $390.4M

• Medifast press release (NYSE:MED): Q3 Non-GAAP EPS of $3.32.
• Revenue of $390.4M (-5.6% Y/Y).
• Outlook: The company now anticipates that full-year 2022 revenue to be in the range of $1.51 billion to $1.59 billion, down from the previously announced range of $1.58 billion to $1.66 billion that was previously disclosed.
• The company expects full-year 2022 non-GAAP diluted EPS to be in the range of $11.61 to $13.05, down from the previously announced range of $12.70 to $14.10.
• "This change in outlook has been prompted by the impact of high inflation and macroeconomic uncertainties on new customer acquisition. The revised full-year 2022 earnings guidance assumes a 24.00% to 25.00% effective tax rate," the management said.